A multi-center,randomized, double-blind, placebo-controlled, phase 2, exploratory study to evaluate the effect of rufinamide on anxiety in patients with moderate to severe generalized anxiety disorder

Trial Profile

A multi-center,randomized, double-blind, placebo-controlled, phase 2, exploratory study to evaluate the effect of rufinamide on anxiety in patients with moderate to severe generalized anxiety disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 24 May 2017

At a glance

  • Drugs Rufinamide (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Sponsors Synosia Therapeutics
  • Most Recent Events

    • 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2008 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
    • 07 Jun 2008 The expected completion date for this trial is now 1 Jan 2009, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top